Sabrina Rossi

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Venues

Cancers

Future oncology (London, England)

Cancer research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Istituto Clinico Humanitas

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto Clinico Humanitas Jul 01 2016

Italy

assistente :: oncology

Publications

Sabrina Rossi, Silvia Masini, Giovanna Finocchiaro, Elena Lorenzi, Luca Toschi, Armando Santoro
Retreatment with Immune Checkpoint Inhibitors in the New Scenario of Immunotherapy in Non-Small Cell Lung Cancer. Cancers 16 (9) (2024)
Sabrina Rossi, Arianna Pagliaro, Giovanna Finocchiaro, Arianna Marinello, Laura Giordano, Emilio Bria, Alessio Stefani, Antonio Vitale, Luca Toschi, Ettore D'Argento, Armando Santoro
Response to first-line pembrolizumab in metastatic KRAS -mutated non-small-cell lung cancer. Future oncology (London, England) (2024)
Sabrina Rossi, Arianna Pagliaro, Giovanna Finocchiaro, Arianna Marinello, Laura Giordano, Emilio Bria, Alessio Stefani, Antonio Vitale, Luca Toschi, Ettore D'Argento, Armando Santoro
Response to first-line pembrolizumab in metastatic KRAS -mutated non-small-cell lung cancer. Future oncology (London, England) 20 (7) (2024)
Sabrina Rossi, Silvia Masini, Giovanna Finocchiaro, Elena Lorenzi, Luca Toschi, Armando Santoro
Retreatment with Immune Checkpoint Inhibitors in the New Scenario of Immunotherapy in Non-Small Cell Lung Cancer. Cancers 16 (9) (2024)
Alessandra Rigamonti, Marika Viatore, Rebecca Polidori, Daoud Rahal, Marco Erreni, Maria Rita Fumagalli, Damiano Zanini, Andrea Doni, Anna Rita Putignano, Paola Bossi, Emanuele Voulaz, Marco Alloisio, Sabrina Rossi, Paolo Andrea Zucali, Armando Santoro, Vittoria Balzano, Paola Nistico, Friedrich Feuerhake, Alberto Mantovani, Massimo Locati, Federica Marchesi
Integrating AI-powered digital pathology and imaging mass cytometry identifies key classifiers of tumor cells, stroma, and immune cells in non-small cell lung cancer. Cancer research (2024)
Alessandra Rigamonti, Marika Viatore, Rebecca Polidori, Daoud Rahal, Marco Erreni, Maria Rita Fumagalli, Damiano Zanini, Andrea Doni, Anna Rita Putignano, Paola Bossi, Emanuele Voulaz, Marco Alloisio, Sabrina Rossi, Paolo Andrea Zucali, Armando Santoro, Vittoria Balzano, Paola Nistico, Friedrich Feuerhake, Alberto Mantovani, Massimo Locati, Federica Marchesi
Integrating AI-Powered Digital Pathology and Imaging Mass Cytometry Identifies Key Classifiers of Tumor Cells, Stroma, and Immune Cells in Non-Small Cell Lung Cancer. Cancer research 84 (7) (2024)
Sabrina Rossi, Arianna Pagliaro, Giovanna Finocchiaro, Arianna Marinello, Laura Giordano, Emilio Bria, Alessio Stefani, Antonio Vitale, Luca Toschi, Ettore D'Argento, Armando Santoro
Response to first-line pembrolizumab in metastatic KRAS -mutated non-small-cell lung cancer. Future oncology (London, England) 20 (7) (2024)
Sabrina Rossi, Arianna Pagliaro, Angelica Michelini, Pierina Navarria, Elena Clerici, Davide Franceschini, Luca Toschi, Giovanna Finocchiaro, Marta Scorsetti, Armando Santoro
The Era of Immunotherapy in Small-Cell Lung Cancer: More Shadows Than Light? Cancers 15 (24) (2023)
Marco Tagliamento, Alessandra Gennari, Matteo Lambertini, Ramón Salazar, Nadia Harbeck, Lucia Del Mastro, Juan Aguilar, Mark Bower, Rachel Sharkey, Alessia Dalla Pria, Andrea Plaja, Amanda Jackson, Jasmine Handford, Ailsa Sita-Lumsden, Clara Martinez-Vila, Marta Matas, Ana Miguel Rodriguez, Bruno Vincenzi, Giuseppe Tonini, Alexia Bertuzzi, Joan Brunet, Paolo Pedrazzoli, Francesca D'Avanzo, Federica Biello, Alasdair Sinclair, Alvin J X Lee, Sabrina Rossi, Gianpiero Rizzo, Oriol Mirallas, Isabel Pimentel, Maria Iglesias, Ana Sanchez de Torre, Annalisa Guida, Rossana Berardi, Alberto Zambelli, Carlo Tondini, Marco Filetti, Francesca Mazzoni, Uma Mukherjee, Nikolaos Diamantis, Maria Concetta Fargnoli, Avinash Aujayeb, Aleix Prat, Michela Libertini, Salvatore Grisanti, Maura Rossi, Federica Zoratto, Daniele Generali, Cristina Saura, Gary H Lyman, Nicole M Kuderer, David James Pinato, Alessio Cortellini, null null
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Sabrina Rossi, Arianna Pagliaro, Angelica Michelini, Pierina Navarria, Elena Clerici, Davide Franceschini, Luca Toschi, Giovanna Finocchiaro, Marta Scorsetti, Armando Santoro
The Era of Immunotherapy in Small-Cell Lung Cancer: More Shadows Than Light? Cancers 15 (24) (2023)
Marco Tagliamento, Alessandra Gennari, Matteo Lambertini, Ramón Salazar, Nadia Harbeck, Lucia Del Mastro, Juan Aguilar, Mark Bower, Rachel Sharkey, Alessia Dalla Pria, Andrea Plaja, Amanda Jackson, Jasmine Handford, Ailsa Sita-Lumsden, Clara Martinez-Vila, Marta Matas, Ana Miguel Rodriguez, Bruno Vincenzi, Giuseppe Tonini, Alexia Bertuzzi, Joan Brunet, Paolo Pedrazzoli, Francesca D'Avanzo, Federica Biello, Alasdair Sinclair, Alvin J X Lee, Sabrina Rossi, Gianpiero Rizzo, Oriol Mirallas, Isabel Pimentel, Maria Iglesias, Ana Sanchez de Torre, Annalisa Guida, Rossana Berardi, Alberto Zambelli, Carlo Tondini, Marco Filetti, Francesca Mazzoni, Uma Mukherjee, Nikolaos Diamantis, Maria Concetta Fargnoli, Avinash Aujayeb, Aleix Prat, Michela Libertini, Salvatore Grisanti, Maura Rossi, Federica Zoratto, Daniele Generali, Cristina Saura, Gary H Lyman, Nicole M Kuderer, David James Pinato, Alessio Cortellini, null null
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Angelo Castello, Sabrina Rossi, Luca Toschi, Egesta Lopci
Impact of Antibiotic Therapy and Metabolic Parameters in Non-Small Cell Lung Cancer Patients Receiving Checkpoint Inhibitors. Journal of clinical medicine 10 (6) (2021)
Sabrina Rossi, Luca Toschi, Giovanna Finocchiaro, Armando Santoro
Neutrophil and lymphocyte blood count as potential predictive indicators of nivolumab efficacy in metastatic non-small-cell lung cancer. Immunotherapy 12 (10) (2020)
Angelo Castello, Sabrina Rossi, Luca Toschi, Luigi Mansi, Egesta Lopci
Soluble PD-L1 in NSCLC Patients Treated with Checkpoint Inhibitors and Its Correlation with Metabolic Parameters. Cancers 12 (6) (2020)
Sabrina Rossi, Giovanna Finocchiaro, Luca Toschi, Armando Santoro
Nivolumab in disadvantaged subgroups of metastatic non-small-cell lung cancer patients: a single-institution experience. Immunotherapy 11 (11) (2019)
Sabrina Rossi, Giovanna Finocchiaro, Vincenzo Di Noia, Maria Bonomi, Eleonora Cerchiaro, Fiorenza De Rose, Davide Franceschini, Pierina Navarria, Giovanni Luca Ceresoli, Giordano Domenico Beretta, Ettore D'Argento, Marta Scorsetti, Armando Santoro, Luca Toschi
Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in oligoprogressive EGFR-mutant non-small-cell lung cancer. Future oncology (London, England) 15 (33) (2019)

Sabrina Rossi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sabrina Rossi